• 

  Developing

  • Developing pharmacokinetic discovery and early development strategies to minimize project cycle times with drug candidates less likely to fail in later development
• 

  Devise strategies

  • Devise strategies for overcoming or exploiting the blood brain barrier
• 

  Human pharmacokinetic predictions

  • Human pharmacokinetic predictions using in vitro or animal in vivo data
• 

  Guide strategies

  • Guide strategies that identify potentially clinically relevant drug-drug interactions so they can be either designed out or mitigated
• 

  Devise early/exploratory clinical development plans

  • Devise early/exploratory clinical development plans that speed to key decisions such as microdosing, low pharmacologically active doses (PADS) and the effective use of biomarkers
• 

  Pharmacokinetics and pharmacodynamics

  • Use pharmacokinetics and pharmacodynamics to design optimum dosage regimens
• 

  Prepare and/or review

  • Prepare and/or review drug metabolism and pharmacokinetic aspects of key documentation including due diligences
• 

  Prepare regulatory documents

  • Prepare regulatory documents such as CTDs and INDs
• 

  Training

  • Training in pharmacokinetics and drug metabolism tailored to meet the specific needs of the pharmaceutical and biotechnology industry